Evidence map›Paper›PMID 42115393›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Empagliflozin mitigates depression-like behavior in diabetic mice via putative CRF

Sachin P Borikar, Mamata S Chavan, Shirish P Jain, Deepak K Lokwani, Deepali N Tapre

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sachin P BorikarDepartment of Pharmacology, Rajarshi Shahu College of Pharmacy, Malvihir, Botha Road, Buldhana, Maharashtra, 443001, India. sachinborikar@gmail.com.
Mamata S ChavanDepartment of Pharmacology, Rajarshi Shahu College of Pharmacy, Malvihir, Botha Road, Buldhana, Maharashtra, 443001, India.
Shirish P JainDepartment of Pharmacology, Rajarshi Shahu College of Pharmacy, Malvihir, Botha Road, Buldhana, Maharashtra, 443001, India. principalrscp@gmail.com.
Deepak K LokwaniDepartment of Pharmaceutical Chemistry, Rajarshi Shahu College of Pharmacy, Buldhana, Maharashtra, 443001, India.
Deepali N TapreDepartment of Pharmaceutical Chemistry, Rajarshi Shahu College of Pharmacy, Buldhana, Maharashtra, 443001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is one of the main cause and major risk factor for the development of neurodegenerative and neuropsychiatric disorders, including depression, with rising prevalence and increasing co-morbidities worldwide. However, the relationship between diabetes and depression in animal models has not been thoroughly investigated. The present study aimed to investigate the antidepressant potential of empagliflozin (EMPA) in diabetic mice subjected to a chronic unpredictable mild stress (CUMS) model, focusing on its interaction with the corticotropin-releasing factor 1 receptor (CRF

Indexed as

Antidepressive AgentsBenzhydryl CompoundsDepressionDiabetes Mellitus, ExperimentalGlucosidesReceptors, Corticotropin-Releasing HormoneAnimalsBehavior, AnimalCRF Receptor, Type 1Hypoglycemic AgentsMaleMiceMolecular Docking SimulationOxidative StressStreptozocinStress, PsychologicalAntidepressive AgentsBenzhydryl CompoundsCRF Receptor, Type 1empagliflozinGlucosidesHypoglycemic AgentsReceptors, Corticotropin-Releasing HormoneStreptozocinAntioxidantCorticosteroneCUMSDiabetesEmpagliflozinFSTMolecular docking and CRF1SGLT2 inhibitorsTST

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.